RTI Health Solutions (RTI-HS)

21/04/2010
11/08/2026
Institution
Not-for-profit
Institution identification

Institution ID

48288

Institution full name and acronym

RTI Health Solutions (RTI-HS)

Institution countries

France
Spain
Sweden
United Kingdom
United Kingdom (Northern Ireland)
United States

Type of institution

Not-for-profit

Institution website

ENCePP partner

Yes
Institution description
RTI is an independent, non-profit research institute with a rich history spanning over sixty-five years. Throughout this time, RTI has been at the forefront of leading research initiatives for both public and private organizations. One of its specialized units, RTI Health Solutions (RTI-HS), is dedicated to advancing pharmaceutical and health research. RTI-HS's areas of expertise include pharmacoepidemiology and real-world evidence (RWE), risk management, benefit-risk evaluation, pharmacovigilance, patient-reported outcomes, health preference assessment, implementation science, medical communications, and more. The team of experts at RTI-HS is located across Europe and the United States, ensuring a broad and diverse geographical spread.
RTI-HS has access to a wide range of real-world healthcare data sources in the Europe, North America and Asia Pacific through established collaborations and research and data partnerships. This enables RTI-HS to conduct high-quality, regulatory grade real-world research and generate valuable insights for healthcare decision-making.
RTI-HS's top experts employ the most innovative methods in their research, including causal inference methods with target trial emulation and external control arm frameworks. These advanced methodologies enable researchers to draw more accurate conclusions about the safety and effectiveness of medicines, vaccines, and medical devices.
For a comprehensive list of RTI-HS publications, please visit www.rtihs.org/publications
Institution details
Experience with collecting data directly from individual patients or respondents:
Yes
Interest in carrying out research that is funded by pharmaceutical companies:
Yes

Contact details